1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Circulating tumor cells and genomic profiling of patients with ERBB2 mutant, HER2 non-amplified metastatic breast cancer treated with neratinib
    Meeting Abstract

    D'Souza, A.; Shishedo, S.; Spicer, D. V.; Welter, L.; Jiang, Y.; Hyman, D. M.; Solit, D. B.; Ma, C. X.; Bose, R.; Cutler, R. E.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Genome-wide association study (GWAS) of chemotherapy-induced Raynaud's phenomenon (RP) to reveal shared pathways with cardiovascular disease (CVD)
    Meeting Abstract

    El Charif, O.; Wheeler, H. E.; Trendowski, M.; Gamazon, E. R.; Ardeshirrouhanifard, S.; Feldman, D. R.; Hamilton, R. J.; Vaughn, D. J.; Beard, C.; Fung, C.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase Ib study of cetuximab + BYL719 + IMRT in stage III-IVB head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Dunn, L.; Riaz, N.; Baxi, S. S.; McBride, S. M.; Sherman, E. J.; Michel, L.; Haque, S.; Katabi, N.; Wong, R. J.; Xiao, H.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Outcomes based on age in the phase 3 METEOR trial of cabozantinib (cabo) vs everolimus (eve) in patients with advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Donskov, F.; Motzer, R. J.; Voog, E.; Hovey, E. J.; Grùˆllich, C.; Nott, L. M.; Cuff, K. E.; Gil, T.; Jensen, N. V.; Chevreau, C.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Changes in CTC burden and prevalence of specific CTC subtypes in mCRPC patients (pts) receiving alpharadin (Ra-223) as single agent or in combination with other therapuetics (Tx)
    Meeting Abstract

    Dittamore, R. V.; Jendrisak, A.; Schreiber, N. A.; McLaughlin, B.; Graf, R.; Rodriguez, A.; Fleisher, M.; Lee, J.; Kelvin, J.; Wang, Y.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Health-related quality of life (HRQoL) of pembrolizumab (pembro) vs chemotherapy (chemo) for previously treated advanced urothelial cancer (UC) in KEYNOTE-045
    Meeting Abstract

    De Wit, R.; Bajorin, D. F.; Bellmunt, J.; Fradet, Y.; Lee, J. L.; Fong, L.; Vogelzang, N. J.; Climent, M. A.; Petrylak, D. P.; Choueiri, T. K.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Borealis-2: A randomized phase II study of OGX-427 (apatorsen) plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial cancer (mUC) (Hoosier Cancer Research Network GU12-160)
    Meeting Abstract

    Choueiri, T. K.; Hahn, N. M.; Werner, L.; Regan, M. M.; Rosenberg, J. E.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Avelumab plus axitinib vs sunitinib as first-line treatment of advanced renal cell carcinoma: Phase 3 study (JAVELIN Renal 101)
    Meeting Abstract

    Choueiri, T. K.; Rini, B. I.; Larkin, J. M. G.; Bjarnason, G. A.; Gravis, G.; Gurney, H.; Lee, J. L.; Keizman, D.; Haanen, J. B. A. G.; Tomita, Y.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Comparison of somatic mutation profiles from cell free DNA (cfDNA) versus tissue in metastatic urothelial carcinoma (mUC)
    Meeting Abstract

    Cheng, M. L.; Shady, M.; Cipolla, C. K.; Funt, S.; Arcila, M. E.; Al-Ahmadie, H.; Rosenberg, J. E.; Bajorin, D. F.; Berger, M. F.; Tsui, D.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Discovery and prevalence of cancer-susceptibility germline mutations (Mts) in patients (Pts) with advanced renal cell carcinoma (aRCC)
    Meeting Abstract

    Carlo, M. I.; Mukherjee, S.; Kemel, Y.; Zhang, L.; Mandelker, D.; Vijai, J.; Coskey, D. T.; Pradhan, N.; Hyman, D. M.; Hakimi, A. A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save